2026-08-25 00:00 China Clinical Launch & Registration Translated from EN

BCIFlex Begins China Trial of Implantable Wireless BCI in Tetraplegia

Summary BCIFlex Medical Technology has begun a clinical trial in China evaluating the safety and efficacy of an implantable wireless brain-computer interface in patients left tetraplegic by spinal cord injury. The trial is registered on ClinicalTrials.gov as NCT07784088 and is recruiting. The sponsor is a Chinese device maker headquartered in the Haidian district of Beijing with an office in Shanghai, working on invasive ultra-thin flexible electrodes; its products include digital EEG systems and stereo-EEG depth electrodes.

Why it matters A supplier of conventional neuro-recording hardware is now sponsoring an implanted-interface study of its own, its first, which is a different order of regulatory and clinical commitment than selling EEG machines and depth electrodes.

BCIwiki (bciwiki.com) — BCIFlex Medical Technology has launched a clinical trial in China to evaluate the safety and efficacy of an implantable wireless brain-computer interface system (IWBCIS) in patients with tetraplegia resulting from spinal cord injury. The trial is registered on ClinicalTrials.gov under NCT07784088 and is currently recruiting participants.

The trial primarily targets patients with tetraplegia or tetraparesis due to cervical spinal cord injury. The study will assess the system's potential in motor decoding and neurological recovery. First posted on August 25, 2026, the trial is sponsored by BCIFlex Medical Technology Co., Ltd.

Compiled by BCIwiki from public sources

Sources · 1

clinicaltrials.gov 2026-08-25

Zhiran Medical Invasive BCI Wireless Implants Tetraplegia China

Zhiran Medical timeline

2026-08 China bet $1B on BCI in 6 months. Who got the money? All entries →

Read original ↗

Suggest a correction Revisions · none 中 / EN